Hyperparathyroidism
📧 Sign up to get email alerts when something new happens for Hyperparathyroidism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis [Phase 1]
Phase 1 trial of KHK7580 for secondary hyperparathyroidism in peritoneal dialysis patients has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Mineral Metabolism and Vascular Effects of Vitamin D Therapy in Kidney Transplant Patients [Phase 4]
Phase 4 trial evaluating mineral metabolism and vascular effects of Vitamin D therapy in kidney transplant patients; the study was terminate…
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate [Phase 4]
This Phase 4 trial update examines the use of strontium ranelate as systemic treatment after surgical management of primary hyperparathyroid…
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis Patients [Phase 4]
A Phase 4 clinical trial update evaluating cinacalcet for secondary hyperparathyroidism in haemodialysis patients; current status is unknown…
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism
A completed clinical trial update studying paricalcitol, a selective vitamin D receptor activator, for prevention and treatment of secondary…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Bioequivalence Study of Paricalcitol Capsules, 4 mcg Under Fasting Conditions [Phase 1]
A Phase 1 bioequivalence study of paricalcitol 4 mcg capsules under fasting conditions in healthy volunteers has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical Practice
This clinical trial update reports long-term outcomes of treating chronic kidney disease patients with paricalcitol in German and Austrian c…
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease [Phase 2]
Phase 2 safety study of CTA018 injection for Stage 5 chronic kidney disease has completed. The trial targeted patients with secondary hyperp…
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis [Phase 4]
Phase 4 trial evaluating cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis was terminated.
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets [Phase 3]
Phase 3 trial investigating paricalcitol to lower parathyroid hormone in familial hypophosphatemic rickets completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-09-30Clinical Trial Update: Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects [Phase 1]
A Phase 1 pharmacokinetics and safety pilot study evaluating single-dose oral and intravenous CTAP101 in stage 3–4 chronic kidney disease ha…
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT) [Phase 1]
This Phase 1 trial compares intravenous CTAP201 with doxercalciferol (Hectorol) in subjects with chronic kidney disease and secondary hyperp…
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)
A completed clinical trial evaluated Zemplar capsules (paricalcitol) for the treatment of secondary hyperparathyroidism in chronic kidney di…
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT) [Phase 4]
Phase 4 trial comparing paricalcitol to calcitriol for efficacy and safety in stage 3/4 chronic kidney disease with secondary hyperparathyro…
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease [Phase 3]
A phase 3 study evaluating sevelamer for secondary hyperparathyroidism in chronic kidney disease has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Quality of Life in Greek Hemodialysis Patients Receiving Zemplar Intravenous
ClinicalTrials.gov update reports a quality-of-life study in Greek hemodialysis patients treated with Zemplar Intravenous (paricalcitol) for…
-
CLINICAL_TRIALS trial_result · 2014-07-21Clinical Trial Update: Vitamin D Status in Males in Jerusalem Area and Its Correlation to Parathyroid Hormone (PTH) Level and Bone Mineral Density [Phase 4]
Phase 4 clinical trial in Jerusalem area evaluating vitamin D status in men and its relationship to parathyroid hormone levels and bone mine…
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: Study to Evaluate the Effect of Intravenous (IV) Paricalcitol (Zemplar) on Cardiac Morbidity in Patients With Chronic Kidney Disease (CKD) Stage 5 Over 2 Years
A completed study evaluated intravenous paricalcitol (Zemplar) for its effect on cardiac morbidity in patients with chronic kidney disease s…
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism [NA]
Clinical trial update on suspected deficient activation of vitamin D in patients with secondary hyperparathyroidism; study completed with re…
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: Observation of Histological Changes in Parathyroid Adenomas Following High Intensity Focused Ultrasound (HIFU) Treatment Procedure [NA]
A completed Theraclion-sponsored clinical trial reports histological changes in parathyroid adenomas following high intensity focused ultras…
-
CLINICAL_TRIALS trial_result · 2014-04-14Clinical Trial Update: How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis [Phase 4]
A Phase 4 trial evaluated the effects of vitamin D analogues on endothelial cells in patients on dialysis with secondary hyperparathyroidism…
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: Acute Effects of Cinacalcet on Arterial Stiffness and Ventricular Function in Hemodialysis Patients [Phase 4]
This document reports the completion of a Phase 4 clinical trial evaluating the acute effects of cinacalcet on arterial stiffness and ventri…
-
CLINICAL_TRIALS trial_result · 2014-03-12Clinical Trial Update: 20070360 Incident Dialysis [Phase 4]
Phase 4 clinical trial update for incident dialysis in chronic kidney disease with secondary hyperparathyroidism; study completed with resul…
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: Observational Program of Zemplar in Patients With End Stage Chronic Kidney Disease and Parathyroid Disorder on Hemodialysis in the Russian Federation
An observational program evaluating Zemplar (paricalcitol) for secondary hyperparathyroidism in end-stage renal disease patients on hemodial…
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis
This completed clinical trial evaluated patient management practices and quality of life for paricalcitol capsules in treating secondary hyp…